Back to results
CompletedPhase 2

Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer

NCT00055861

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Colorado Cancer Center - Anschutz Cancer Pavilion

Aurora, Colorado, United States

+1 additional location

View on ClinicalTrials.gov
Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer — TrialFind